Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Ceapro Inc V.CZO

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human, and animal health industries using technology, natural, renewable resources, and developing products, technologies, and delivery systems. The Company's products include a commercial line of natural active ingredients, including beta glucan, avenanthramides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides, a commercial line of natural anti-aging skincare products, utilizing active ingredients, including beta glucan and avenanthramides and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner.


TSXV:CZO - Post by User

Bullboard Posts
Comment by billy4325on Jun 13, 2018 7:19pm
108 Views
Post# 28168960

RE:RE:Joint ventures should be welcomed!

RE:RE:Joint ventures should be welcomed!
digitel wrote: "As said in recent post, lot of progress has been acheived in the last 6 months. The problem is that we don't see light at the end of the tunnel. I personnaly think that a JV with a dynamic partner could be a catalyst for the appreciation of shareholders value. If the management does not act fast enough..."

As said on pg. 26 of the AGM presentation, partnering and sales are next! The company has said that a functional beverage could be ready for sale by the end of the year and that is only six months away. Hard to be quicker. To reach that a deal will have to happen quickly. The CEO has also said that companies are "extremely, extremely" interested.



The cholesterol nutraceutical was supposed to reach clinical stage in Q4 2016.  The operations at the old plant were going to run in parallel with the new plant until Q1 2017.  Yet here we are well in 2018.  I'm not too confident in the company's abilities to meet any of its deadlines.   

Bullboard Posts